Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
12.26 USD | +3.07% | -8.34% | -43.95% |
Apr. 25 | Truist Securities Cuts Sage Therapeutics' Price Target to $18 From $22, Hold Rating Maintained | MT |
Apr. 25 | Transcript : Sage Therapeutics, Inc., Q1 2024 Earnings Call, Apr 25, 2024 |
- Stock Market
- Equities
- SAGE Stock
- News Sage Therapeutics, Inc.